Page 24 - Škrgat, Sabina, ed. 2022. Severe Asthma - Basic and Clinical Views. Koper: University of Primorska Press. Severe Asthma Forum, 1

Allergy Clin Immunol Pract. 2017 Sep-
Oct;5(5S):S15-S24.
severe asthma forum 1: severe asthma - basic and clinical views 17. Rijavec M, Krumpestar T, Škrgat S, et
al. T2-high asthma, classified by spu-
tum mrna expression of L4, IL5, and
IL13, is characterized by eosinophil-
ia and severe phenotype. Life. 2021 Jan
27;11(2):92. doi: 10.3390/life11020092.
18. Schoettler N, Strek ME. Recent Ad-
vances in Severe Asthma: From Pheno-
types to Personalized Medicine. Chest.
2020 Mar;157(3):516-528.
19. Šokić Kopač M, Rijavec M, Korošec
P, et al. Heterogeneous Response of
Airway Eosinophilia to Anti-IL-5
Biologics in Severe Asthma Patients.
J Pers Med. 2022 Jan 7;12(1):70. doi:
10.3390/jpm12010070.
20. Van Hulst G, Bureau F, Desmet CJ. Eo-
sinophils as drivers of severe eosinophil-
ic asthma: Endotypes or plasticity? Int
J Mol Sci. 2021 Sep;22(18):10150. doi:
10.3390/ijms221810150.